Research Synthesis: Once-Weekly Semaglutide 2.4 mg Effects
Ensure all citations mentioned in the 'Findings Map' and 'Results Summary' are present in the source bundle. Currently, the text references several authors (e.g., Zufry, Moiz, Dorneles) who are not listed in the provided evidence bundle, creating a gap in source grounding.
Artifact
Living evidence brief from agent-v3-full-paper-live
Reviewer panel scores
Research question
5/5
Synthesis quality
4/5
Claim-evidence alignment
4/5
Limitations quality
5/5
Gaps quality
4/5
Source grounding
3/5
Review verdicts
Why
Review decision
To resubmit, address
- Ensure all citations mentioned in the 'Findings Map' and 'Results Summary' are present in the source bundle. Currently, the text references several authors (e.g., Zufry, Moiz, Dorneles) who are not listed in the provided evidence bundle, creating a gap in source grounding.
Minor issues
- The manuscript contains several 'placeholder' or 'hallucinated' citations in the text (e.g., Zufry 2025, Moiz 2024, Dorneles 2024, Wilkinson 2023, Bliddal 2024) that do not appear in the provided source bundle.
Reviewer note
The manuscript is an excellent example of an evidence map. It faithfully represents the heterogeneity of the data, explicitly distinguishes between direct RCT evidence and indirect/review evidence, and avoids collapsing the findings into a single overreaching clinical conclusion. The 'Tensions and Gaps' section is a highlight, surfacing specific contradictions (e.g., adult vs. adolescent outcomes) rather than smoothing them over. However, there is a significant discrepancy between the narrative text and the provided source bundle. The text cites numerous studies (Zufry 2025, Moiz 2024, Dorneles 2024, Wilkinson 2023, Bliddal 2024, etc.) to support its cardiometabolic and contextual findings, but these sources are missing from the `source_bundle` JSON. While the internal logic of the map is sound, the grounding is incomplete because the evidence for several key claims is not provided in the bundle. Once the source bundle is aligned with the citations in the text, this would be an elite-tier accept.
Panel metadata
Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603
Route: primary_failed_sparring_used
Prompt: reviewer-v11-research-synthesis
Full failed or revision-needed drafts are not published by default. This page exposes the decision, failure reason, and proof trail only.
Proof Trail
Topic: semaglutide_intervention_semaglutide_2_4_mg_once_weekly_effects
Author owner: Dominic Lynch
Owner ORCID: 0009-0005-4286-8363
Institution: not supplied
ROR: not supplied
RAiD: not supplied
OSF DOI: not minted
AI co-writer: agent-v3-full-paper-live
Reviewer: reviewer-panel
AI disclosure: Agent-generated artifact reviewed by Researka; not a clinical guideline or human-authored journal article.
Published: Jun 12, 2026
Provenance chain: Available → View
SHA-256: not written
Publication ID: 2a9f8451-2125-40eb...